Department of Paediatrics, Finnmark Hospital Trust, Hammerfest, Norway.
Paediatric Research Group, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Acta Paediatr. 2020 Jan;109(1):183-192. doi: 10.1111/apa.14916. Epub 2019 Jul 30.
Long-term evaluations of childhood obesity treatments are needed. We examined changes in weight and cardiometabolic risk 1 year after children completed individual family or group-based weight management interventions.
In 2009-2010, 6- to 12-year-old children with overweight or obesity from Finnmark and Troms (Norway) were recruited after media coverage and randomised to 24 months of individual family (n = 49) or group intervention (n = 48). Individual family intervention included counselling by a paediatric hospital team and a public health nurse in the local community. Group intervention included meetings with other families and a multidisciplinary hospital team, weekly physical activity sessions and a family camp. The primary outcome body mass index (BMI) and cardiometabolic risk factors were analysed 12 months after intervention.
From baseline to 36 months, children's BMI increased 3.0 kg/m in individual family and 2.1 kg/m in group intervention (between-group -0.9kg/m , P = 0.096). Data were available from 62 children (64%). Between-group differences in C peptide (P = 0.01) were detected in favour of group intervention. Pooled data from both treatment groups showed continued decrease in BMI standard deviation score (P < 0.001).
No between-group difference in BMI was observed 12 months after intervention. Both groups combined showed sustained decrease in BMI standard deviation score.
需要对儿童肥胖治疗进行长期评估。我们检测了儿童完成个体化家庭或基于小组的体重管理干预后 1 年时体重和心血管代谢风险的变化。
2009-2010 年,在媒体报道后,挪威芬马克和特罗姆瑟地区招募了 6-12 岁超重或肥胖的儿童,并对他们进行了随机分组,接受 24 个月的个体化家庭(n=49)或小组干预(n=48)。个体化家庭干预包括由儿科医院团队和当地社区的公共卫生护士进行咨询。小组干预包括与其他家庭和多学科医院团队会面、每周进行体育活动以及家庭露营。主要结局指标是干预后 12 个月的体重指数(BMI)和心血管代谢危险因素。
从基线到 36 个月,个体化家庭组儿童的 BMI 增加了 3.0kg/m2,小组干预组增加了 2.1kg/m2(组间差异-0.9kg/m2,P=0.096)。共有 62 名儿童(64%)提供了数据。小组干预组的 C 肽(P=0.01)存在组间差异,对小组干预组有利。来自两个治疗组的汇总数据显示 BMI 标准差评分持续下降(P<0.001)。
干预后 12 个月时,两组间 BMI 无差异。两组合并显示 BMI 标准差评分持续下降。